AKT1 and neoplasm: The work of Fearon et al. provides a novel mechanism for the PHLDA family, particularly PHLDA1, as generally being a global tumor suppressor by inhibiting AKT signaling as cancer cells undergo selective pressures from chemotherapeutics.